in

Everest Medicines Announces Taiwan TFDA Approval of NEFECON for the Treatment of Primary IgA Nephropathy

Source link : https://www.yourblogdomain.com/2024/10/25/everest-medicines-announces-taiwan-tfda-approval-of-nefecon-for-the-treatment-of-primary-iga-nephropathy/

Source link : https://news7.asia/news/everest-medicines-announces-taiwan-tfda-approval-of-nefecon-for-the-treatment-of-primary-iga-nephropathy/ SHANGHAI, Oct 21, 2024 – (ACN Newswire) – Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announces that the Taiwan Food and Drug Administration (TFDA) has approved NEFECON® indicated “to reduce the loss of kidney […]

Author : yourblogdomain

Publish date : 2024-10-25 05:04:42

Copyright for syndicated content belongs to the linked Source.

Thursday Night Football: Matthew Stafford throws four TDs, Rams beat Vikings 30-20

Saint Lucia Cruise Port Hosts Inaugural Cruise Connect Conference, celebrating growth and envisioning a bright future